Acme United Q2 sales rise on acquisitions, broad growth

Acme United Corporation

Acme United Corporation

ACU

0.00


Overview

  • Safety solutions supplier's Q2 net sales rose 16% yr/yr, driven by broad-based growth

  • Q2 net income increased 6% yr/yr; diluted EPS up 5%

  • Gross margin improved to 42.6%, aided by My Medic acquisition


Outlook

  • Company expects My Medic business to generate most profitability in Q4

  • Company anticipates high tariffs will continue to pressure margins, but at a decreasing rate

  • Acme United aims for strengthening quarterly profitability through cost reductions and growth initiatives


Result Drivers

  • ACQUISITION IMPACT - My Medic acquisition contributed to sales growth but had minimal effect on Q2 earnings due to seasonal profit pattern

  • U.S. SALES GROWTH - U.S. first aid sales excluding My Medic rose 10% and Westcott cutting tools sales grew 8%, helped by renewed promotional activity and stronger retail demand

  • TARIFF PRESSURE - Elevated tariffs continued to weigh on U.S. gross margins, though the impact was less than in Q1


Company press release: ID:nGNX9SY6sR


Key Details

Metric

Beat/Miss

Actual

Consensus Estimate

Q2 Sales

Beat

$62.72 mln

$56.24 mln (2 Analysts)

Q2 Net Income

$5.05 mln

Q2 Basic EPS

$1.32

Q2 Gross Profit

$26.69 mln

Q2 Operating Income

$6.83 mln

Q2 Pretax Profit

$6.30 mln


Analyst Coverage

  • The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 1 "strong buy" or "buy", 1 "hold" and no "sell" or "strong sell"

  • The average consensus recommendation for the medical equipment, supplies & distribution peer group is "buy"

  • Wall Street's median 12-month price target for Acme United Corp is $50.00, about 8.9% above its July 22 closing price of $45.90

  • The stock recently traded at 25 times the next 12-month earnings vs. a P/E of 21 three months ago


Reuters Recommended Reads

  • July 21 - 3M boosts annual profit forecast driven by resilient industrial unit

  • July 21 - Sweden's MedCap Q2 net sales rise 16% on organic growth and acquisitions

  • July 22 - Graco Q2 sales rise less than expected


For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.